New diabetes clinical trial: Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
Published on: May 07, 2024 at 11:00PM
Conditions: Diabetes Mellitus, Type 2
Interventions: Drug: Semaglutide; Drug: Cagrilintide; Drug: Placebo semaglutide; Drug: Placebo cagrilintide
Sponsors: Novo Nordisk A/S
Not yet recruiting
https://ift.tt/MPeiK3B
Conditions: Diabetes Mellitus, Type 2
Interventions: Drug: Semaglutide; Drug: Cagrilintide; Drug: Placebo semaglutide; Drug: Placebo cagrilintide
Sponsors: Novo Nordisk A/S
Not yet recruiting
https://ift.tt/MPeiK3B
Comments
Post a Comment